Rhythm Pharmaceuticals, Inc. (RYTM) Q3 2024 Earnings Call Transcript

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q3 2024 Earnings Conference Call November 5, 2024 5:00 PM ET

Company Participants

David Connolly - Head of Investor Relations and Corporate Communications
David Meeker - Chairman, President and Chief Executive Officer
Jennifer Lee - Executive Vice President and Head of North America
Yann Mazabraud - Executive Vice President and Head of International
Hunter Smith - Chief Financial Officer

Conference Call Participants

Philip Nadeau - TD Cowen
Corinne Johnson - Goldman Sachs Group, Inc.
Seamus Fernandez - Guggenheim Securities
Dae Gon Ha - Stifel, Nicolaus & Company, Inc.
Whitney Ijem - Canaccord Genuity Corp.
Jeff Hung - Morgan Stanley
Tazeen Ahmad - Bank of America Merrill Lynch
Joseph Stringer - Needham & Company
Raghuram Selvaraju - H.C. Wainwright & Co.

Operator

Good day, and thank you for standing by. Welcome to the Rhythm Pharmaceuticals Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your speaker today, David Connolly, Head of Investor Relations and Corporate Communications. Please go ahead.

David Connolly

Thank you, Shannon. I'm Dave Connolly here at Rhythm Pharmaceuticals. For those of you participating on the conference call, our slides can be accessed and controlled by going to the Investors section of our website, ir.rhythmtx.com. This afternoon, we issued our press release that provides our third quarter 2024 financial results and business update, and that press release is available on our website.

We are coming to you today from San Antonio, the site of ObesityWeek, the annual meeting of The Obesity Society. Listed on Slide 2 is our agenda. On the call today are David Meeker, our Chairman, Chief Executive Officer and President; Jennifer